Abstract
Human noroviruses are the causative agents of non-bacterial gastroenteritis worldwide. The rapid onset and resolution of disease symptoms suggest that innate immune responses are critical for controlling norovirus infection; however, no effective antivirals are yet available. The present study was conducted to examine the antiviral activities of Schizonepeta tenuifolia Briquet extract (STE) against noroviruses. Treatment of human norovirus replicon-bearing HG23 cells with STE at 5 and 10 mg/ml concentrations resulted in the reduction in the viral RNA levels by 77.2% and 85.9%, respectively. STE had no cytotoxic effects on HG23 cells. Treatment of RAW 264.7 cells infected with murine norovirus 1 (MNV-1), a surrogate virus of human noroviruses, with STE at 10 and 20 µg/ml concentrations resulted in the reduction of viral replication by 58.5% and 84.9%, respectively. STE treatment induced the expression of mRNAs for type I and type II interferons in HG23 cells and upregulated the transcription of interferon-β in infected RAW 264.7 cells via increased phosphorylation of interferon regulatory factor 3, a critical transcription regulator for type I interferon production. These results suggest that STE inhibits norovirus replication through the induction of antiviral interferon production during virus replication and may serve as a candidate antiviral substance for treatment against noroviruses.
Similar content being viewed by others
References
Baldridge, M.T., Turula, H., and Wobus, C.E. 2016. Norovirus regulation by host and microbe. Trends Mol. Med. 22, 1047–1059.
Bok, K. and Green, K.Y. 2012. Norovirus gastroenteritis in immunocompromised patients. N. Engl. J. Med. 367, 2126–2132.
Byun, M.W. 2014. Schizonepeta tenuifolia ethanol extract exerts antiinflammatory activity through the inhibition of TLR4 signaling in lipopolysaccharide-stimulated macrophage cells. J. Med. Food 17, 350–356.
Chang, K.O. and George, D.W. 2007. Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells. J. Virol. 81, 12111–12118.
Chang, K.O., Sosnovtsev, S.V., Belliot, G., King, A.D., and Green, K.Y. 2006. Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line. Virology 353, 463–473.
Changotra, H., Jia, Y., Moore, T.N., Liu, G., Kahan, S.M., Sosnovtsev, S.V., and Karst, S.M. 2009. Type I and type I interferons inhibit the translation of murine norovirus proteins. J. Virol. 83, 5683–5692.
Chen, S.G., Cheng, M.L., Chen, K.H., Horng, J.T., Liu, C.C., Wang, S.M., Sakurai, H., Leu, Y.L., Wang, S.D., and Ho, H.Y. 2017. Antiviral activities of Schizonepeta tenuifolia Briq. against enterovirus 71 in vitro and in vivo. Sci. Rep. 7, 935.
Cho, H.J., Jeong, S.G., Park, J.E., Han, J.A., Kang, H.R., Lee, D., and Song, M.J. 2013. Antiviral activity of angelicin against gammaherpesviruses. Antiviral Res. 100, 75–83.
Chun, M.H., Kim, E.K., Lee, K.R., Jung, J.H., and Hong, J. 2010. Quality control of Schizonepeta tenuifolia Briq by solid-phase microextraction gas chromatography/mass spectrometry and principal component analysis. Microchem. J. 95, 25–31.
Doyle, A., Barataud, D., Gallay, A., Thiolet, J., Le, S.G., Kohli, E., and Vaillant, V. 2004. Norovirus foodborne outbreaks associated with the consumption of oysters from the Etang de Thau, France, Decembe 2002. Euro Surveill. 9, 24–26.
Estes, M.K., Prasad, B.V., and Atmar, R.L. 2006. Noroviruses everywhere: has something changed? Curr. Opin. Infect. Dis. 19, 467–474.
Fung, D. and Lau, C.B. 2002. Schizonepeta tenuifolia: chemistry, pharmacology, and clinical applications. J. Clin. Pharmacol. 42, 30–36.
Glass, R.I., Parashar, U.D., and Estes, M.K. 2009. Norovirus gastroenteritis. N. Engl. J. Med. 361, 1776–1785.
Green, K. 2013. Caliciviridae: the noroviruses, pp. 508–609. In Knipe, D.M., Howley, P.M., Cohen, J.I., Griffin, D.E., Lamb, R.A., and Martin, M.A. (eds.), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA,USA.
Honda, K., Takaoka, A., and Taniguchi, T. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349–360.
Hutson, A.M., Atmar, R.L., and Estes, M.K. 2004. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol. 12, 279–287.
Hwang, S., Maloney, N.S., Bruinsma, M.W., Goel, G., Duan, E., Zhang, L., Shrestha, B., Diamond, M.S., Dani, A., Sosnovtsev, S.V., et al. 2012. Nondegradative role of Atg5-Atg12/Atg16L1 autophagy protein complex in antiviral activity of interferon gamma. Cell Host Microbe 11, 397–409.
Kageyama, T., Kojima, S., Shinohara, M., Uchida, K., Fukushi, S., Hoshino, F.B., Takeda, N., and Katayama, K. 2003. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J. Clin. Microbiol. 41, 1548–1557.
Kang, H., Han, S.W., Hong, J.W., and Sohn, N.W. 2010. Suppression of tumour necrosis factor-α by Schizonepeta tenuifolia water extract via inhibition of IκBα degradation and Jun N-terminal kin ase/stress-activated protein kinase activation. J. Pharm. Pharmacol. 62, 1069–1076.
Karst, S.M., Wobus, C.E., Lay, M., Davidson, J., and Virgin, H.W. 2003. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299, 1575–1578.
Kim, Y.H., Jang, S.J., Park, J.Y., Oh, J.H., Kim, G.S., Kim, T.S., Kwon, O.S., Han, J.S., and Jheong, W.H. 2011. Recovery and adsorption rate of murine norovirus using NanoCeram® filters. J. Bacteriol. Virol. 41, 55–61.
Kim, S. and Ko, G. 2012. Using propidium monoazide to distinguish between viable and nonviable bacteria, MS2 and murine norovirus. Lett. Appl. Microbiol. 55, 182–188.
Kim, Y.W., You, H.J., Lee, S., Kim, B., Kim, D.K., Choi, J.B., Kim, J.A., Lee, H.J., Joo, I.S., and Lee, J.S. 2017. Inactivation of norovirus by lemongrass essential oil using a norovirus surrogate system. J. Food Prot. 80, 1293–1302.
Kirby, A.J. and Schmidt, R.J. 1997. The antioxidant activity of Chinese herbs for eczema and of placebo herbs-I. J. Ethnopharmacol. 56, 103–108.
Koo, H.S., Lee, M.O., Ku, P.T., Hwang, S.J., Park, D.J., and Baik, H.S. 2016. Molecular epidemiology of norovirus in asymptomatic food handlers in Busan, Korea, and emergence of genotype GII. 17. J. Microbiol. 54, 686–694.
Ma, S.C., Du, J., But, P.P.H., Deng, X.L., Zhang, Y.W., Ooi, V.E.C., Xu, H.X., Lee, S.H.S., and Lee, S.F. 2002. Antiviral Chinese medicinal herbs against respiratory syncytial virus. J. Ethnopharmacol. 79, 205–211.
McCartney, S.A., Thackray, L.B., Gitlin, L., Gilfillan, S., Virgin IV, H.W., and Colonna, M. 2008. MDA-5 recognition of a murine norovirus. PLoS Pathog. 4, e1000108.
McFadden, N., Bailey, D., Carrara, G., Benson, A., Chaudhry, Y., Shortland, A., Heeney, J., Yarovinsky, F., Simmonds, P., Macdonald, A., et al. 2011. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog. 7, e1002413.
Mumphrey, S.M., Changotra, H., Moore, T.N., Heimann-Nichols, E.R., Wobus, C.E., Reilly, M.J., Moghadamfalahi, M., Shukla, D., and Karst, S.M. 2007. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J. Virol. 81, 3251–3263.
Ng, Y.C., Kim, Y.W., Ryu, S., Lee, A., Lee, J.S., and Song, M.J. 2017. Suppression of norovirus by natural phytochemicals from Aloe vera and Eriobotryae Folium. Food Control 73, 1362–1370.
Nice, T.J., Baldridge, M.T., McCune, B.T., Norman, J.M., Lazear, H.M., Artyomov, M., Diamond, M.S., and Virgin, H.W. 2015. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Science 347, 269–273.
Park, I.K., Kim, L.S., Choi, I.H., Lee, Y.S., and Shin, S.C. 2006. Fumigant activity of plant essential oils and components from Schizonepeta tenuifolia against Lycoriella ingenua (Diptera: Sciaridae). J. Econ. Entomol. 99, 1717–1721.
Payne, D.C., Vinjé, J., Szilagyi, P.G., Edwards, K.M., Staat, M.A., Weinberg, G.A., Hall, C.B., Chappell, J., Bernstein, D.I., Curns, A.T., et al. 2013. Norovirus and medically attended gastroenteritis in USchildren. N. Engl. J. Med. 368, 1121–1130.
Roth, A.N. and Karst, S.M. 2016. Norovirus mechanisms of immune antagonism. Curr. Opin. Virol. 16, 24–30.
Thackray, L.B., Duan, E., Lazear, H.M., Kambal, A., Schreiber, R.D., Diamond, M.S., and Virgin, H.W. 2012. Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon- mediated control of murine norovirus replication. J. Virol. 86, 13515–13523.
Wobus, C.E., Thackray, L.B., and Virgin, H.W. 2006. Murine norovirus: a model system to study norovirus biology and pathogenesis. J. Virol. 80, 5104–5112.
Yoneyama, M., Suhara, W., and Fujita, T. 2002. Control of IRF-3 activation by phosphorylation. J. Interferon. Cytokine Res. 22, 73–76.
Yoon, M.Y., Lee, H.J., Lee, B.B., Lee, S.M., Kim, J.Y., Kim, Y., Park, E., and Park, H.R. 2007. Protective effect of Schizonepeta tenuifolia Briquet extracts on oxidative DNA damage in human leucocytes and on hydrogen peroxide-induced cytotoxicity in PC12 cells. Food Sci. Biotechnol. 16, 858–862.
Yu, S., Chen, Y., Zhang, L., Shan, M., Tang, Y., and Ding, A. 2011. Quantitative comparative analysis of the bio-active and toxic constituents of leaves and spikes of Schizonepeta tenuifolia at different harvesting times. Int. J. Mol. Sci. 12, 6635–6644.
Zheng, D.P., Ando, T., Fankhauser, R.L., Beard, R.S., Glass, R.I., and Monroe, S.S. 2006. Norovirus classification and proposed strain nomenclature. Virology 346, 312–323.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ng, Y.C., Kim, Y.W., Lee, JS. et al. Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons. J Microbiol. 56, 683–689 (2018). https://doi.org/10.1007/s12275-018-8228-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-018-8228-7